| A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects (NCT01579461) | Astellas Pharma Europe B.V. | 2008-11-01 |
| Variation in Serum Levels of Metformin in Patients With Reduced Renal Function (NCT00767351) | Skane University Hospital | 2008-10-01 |
| Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population (NCT00810316) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-10-01 |
| Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU (NCT00747721) | Orion Corporation, Orion Pharma | 2008-09-01 |
| Pharmacokinetic Study of Raltegravir in Healthy Premenopausal Women. (NCT00746499) | University of North Carolina, Chapel Hill | 2008-09-01 |
| A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice (NCT00984009) | Mutual Pharmaceutical Company, Inc. | 2008-09-01 |
| a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients (NCT01055964) | Seoul National University Hospital | 2008-09-01 |
| Drug-Drug Interaction Between Colchicine and Verapamil ER (NCT00983242) | Mutual Pharmaceutical Company, Inc. | 2008-09-01 |
| The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males (NCT01276119) | UCB Pharma | 2008-09-01 |
| A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis (NCT00730145) | Pfizer | 2008-09-01 |
| A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects (NCT00856570) | Astellas Pharma Inc | 2008-09-01 |
| Crossover Study of the Safety and PK Properties of Proellex® (NCT00749879) | Repros Therapeutics Inc. | 2008-08-11 |
| Drug-Drug Interaction Study of Colchicine and Theophylline (NCT00983905) | Mutual Pharmaceutical Company, Inc. | 2008-08-01 |
| Drug-Drug Interaction Study Between Colchicine and Cyclosporine (NCT00983931) | Mutual Pharmaceutical Company, Inc. | 2008-08-01 |
| Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton (NCT00748046) | Bayer | 2008-08-01 |
| A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function. (NCT00721422) | Pfizer | 2008-08-01 |
| RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE (NCT01082146) | Sumitomo Pharma America, Inc. | 2008-08-01 |
| Drug-Drug Interaction Between Colchicine and Ritonavir (NCT00983515) | Mutual Pharmaceutical Company, Inc. | 2008-07-01 |
| Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin (NCT00722956) | AstraZeneca | 2008-07-01 |
| Drug-Drug Interaction Study Between Colchicine and Ketoconazole (NCT00983216) | Mutual Pharmaceutical Company, Inc. | 2008-07-01 |
| Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin (NCT00723424) | AstraZeneca | 2008-07-01 |
| An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation (NCT00731562) | Pfizer | 2008-07-01 |
| Drug-Drug Interaction Study of Colchicine and Azithromycin (NCT00983294) | Mutual Pharmaceutical Company, Inc. | 2008-07-01 |
| Pharmacogenetics of Bupropion Metabolism (NCT00791869) | University of California, San Francisco | 2008-06-01 |
| An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers (NCT00721448) | AstraZeneca | 2008-06-01 |
| Formulation and Food Effect Study of AZD1386 in Healthy Volunteers (NCT00714337) | AstraZeneca | 2008-06-01 |
| Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing® (NCT00710606) | Columbia University | 2008-06-01 |
| A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents (NCT00556998) | Pfizer | 2008-06-01 |
| TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing. (NCT00741169) | Tibotec Pharmaceuticals, Ireland | 2008-06-01 |
| Pharmacokinetics, Metabolism and Analgesic Effects of Flupirtine (NCT01676246) | University Medicine Greifswald | 2008-05-01 |
| Study Evaluating the Pharmacokinetic Profile of RhuDex® in a Tablet Formulation (NCT00704119) | MediGene | 2008-05-01 |
| A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe (NCT00681525) | Abbott | 2008-04-01 |
| TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet (NCT00752310) | Tibotec Pharmaceuticals, Ireland | 2008-04-01 |
| Antiretroviral Drug Levels During and After Pregnancy (NCT00616252) | Makerere University | 2008-02-01 |
| A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets at Steady State (NCT01121926) | Labopharm Inc. | 2008-01-01 |
| Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study (NCT01018420) | Mutual Pharmaceutical Company, Inc. | 2007-11-01 |
| Drug-Drug Interaction Study of Colchicine and Clarithromycin (NCT00984061) | Mutual Pharmaceutical Company, Inc. | 2007-11-01 |
| Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene (NCT00550485) | Max-Planck-Institute of Psychiatry | 2007-10-01 |
| Population Pharmacokinetics of Dexmedetomidine in ICU Patients (NCT00714857) | University of Turku | 2007-10-01 |
| Phase 1 Pharmacokinetics of Intravenous Nexium in Children (NCT00474019) | AstraZeneca | 2007-10-01 |
| Pharmacokinetic Study With Colchicine in Healthy Volunteers (NCT01017003) | Mutual Pharmaceutical Company, Inc. | 2007-09-01 |
| Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects (NCT00621699) | University Medicine Greifswald | 2007-09-01 |
| Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex® (NCT00532012) | MediGene | 2007-09-01 |
| Pharmacokinetic Study of an Acute Gout Regimen (NCT01017042) | Mutual Pharmaceutical Company, Inc. | 2007-09-01 |
| PET Imaging of Nicotinic Acetylcholine Receptors (NCT01046513) | National Institute on Drug Abuse (NIDA) | 2007-08-31 |
| A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects (NCT00549666) | Sumitomo Pharma America, Inc. | 2007-08-01 |
| Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine (NCT00520104) | Javelin Pharmaceuticals | 2007-08-01 |
| Drug - Drug Interaction Study Between Quinine Sulfate and Theophylline (NCT00779259) | Mutual Pharmaceutical Company, Inc. | 2007-08-01 |
| Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation (NCT01037608) | National Institute on Drug Abuse (NIDA) | 2007-05-08 |
| A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication (NCT00482963) | University of Colorado, Denver | 2007-05-01 |
| Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects (NCT00621101) | University Medicine Greifswald | 2007-04-01 |
| A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects (NCT01657981) | Astellas Pharma Europe B.V. | 2007-02-01 |
| Mechanisms Underlying Drug-Diet Interactions (NCT01034124) | University of North Carolina, Chapel Hill | 2007-01-01 |
| A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System (NCT00614029) | Zogenix, Inc. | 2006-12-01 |
| Pharmacokinetic Study With Repeated Doses of Stalevo (NCT00693862) | Orion Corporation, Orion Pharma | 2006-12-01 |
| Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® (NCT01420211) | University Medicine Greifswald | 2006-10-01 |
| Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine (NCT00856752) | Norgine | 2006-06-01 |
| A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body (NCT01655056) | Astellas Pharma Europe B.V. | 2006-06-01 |
| Evaluating the Effect of Food on Absorption of Megace ES (NCT00638079) | Endo USA Inc., a Keenova Therapeutics Company | 2006-06-01 |
| A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights (NCT00298857) | Northwell Health | 2006-03-01 |
| Metabolism of the Insecticide Permethrin (NCT00572884) | University of California, Davis | 2006-02-01 |
| A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women. (NCT00709982) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-05-01 |
| Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. (NCT00709189) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-05-01 |
| To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females (NCT01478503) | Astellas Pharma Inc | 2005-05-01 |
| Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers (NCT03956134) | Grünenthal GmbH | 2005-04-01 |
| Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. (NCT00709644) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-04-01 |
| Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra (NCT00176033) | Heidelberg University | 2005-01-01 |
| A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women. (NCT00709332) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-01-01 |
| A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery (NCT00644176) | Pfizer | 2004-11-01 |
| Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH (NCT00176085) | Heidelberg University | 2004-10-01 |
| Bioavailability Study of Folic Acid in Healthy Women (NCT00709267) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-10-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects (NCT03776110) | Grünenthal GmbH | 2004-09-15 |
| BlueCQ Bioavailability (NCT00176072) | Heidelberg University | 2004-08-01 |
| Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours (NCT03770234) | Grünenthal GmbH | 2004-04-05 |
| Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets (NCT01465633) | Heidelberg University | 2003-08-01 |
| A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions (NCT00834288) | Labopharm Inc. | 2003-06-01 |
| Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 100 μg/ 75 μg Tablets (NCT01465646) | Heidelberg University | 2003-06-01 |
| A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers (NCT00645554) | Xian-Janssen Pharmaceutical Ltd. | |